Terminated PHASE1 INTERVENTIONAL 2-arm NCT01479998

Novel Treatments to Enhance Smoking Cessation Before Cancer Surgery: Effects on Smoking and Surgical Outcomes

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions standard care standard care plus contingency management

Updated 6 times since 2017 Last updated: Mar 4, 2020 Started: Nov 30, 2011 Primary completion: Jun 30, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Reevaluating recruitment strategies

Other terminated trials from National Institute on Drug Abuse (NIDA)

See all terminations from National Institute on Drug Abuse (NIDA)

Other Smoking Cessation trials with similar outcome

Browse all Smoking Cessation trials

Listed as NCT01479998, this PHASE1 trial focuses on Smoking Cessation and remains terminated or withdrawn. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Apr 2020 — Jan 2021 [monthly]

Terminated PHASE1
Jun 2018 — Apr 2020 [monthly]

Terminated PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States